Abstract
To characterize genetic variation of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) transmitted in the Beijing area during the epidemic outbreak of 2003, we sequenced 29 full-length S genes of SARS-CoV from 20 hospitalized SARS patients on our unit, the Beijing 302 Hospital. Viral RNA templates for the S-gene amplification were directly extracted from raw clinical samples, including plasma, throat swab, sputum, and stool, during the course of the epidemic in the Beijing area. We used a TA-cloning assay with direct analysis of nested reverse transcription-polymerase chain reaction products in sequence. One hundred thirteen sequence variations with nine recurrent variant sites were identified in analyzed S-gene sequences compared with the BJ01 strain of SARS-CoV. Among them, eight variant sites were, we think, the first documented. Our findings demonstrate the coexistence of S-gene sequences with and without substitutions (compared to BJ01) in samples analyzed from some patients.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adult
-
Aged
-
China / epidemiology
-
Communicable Diseases, Emerging / epidemiology
-
Communicable Diseases, Emerging / transmission
-
Communicable Diseases, Emerging / virology
-
Disease Outbreaks*
-
Female
-
Genetic Variation*
-
Hospitalization*
-
Humans
-
Male
-
Membrane Glycoproteins / genetics
-
Middle Aged
-
RNA, Viral / analysis
-
RNA, Viral / isolation & purification
-
Reverse Transcriptase Polymerase Chain Reaction
-
Sequence Analysis, DNA
-
Severe Acute Respiratory Syndrome / epidemiology*
-
Severe Acute Respiratory Syndrome / transmission
-
Severe Acute Respiratory Syndrome / virology
-
Severe acute respiratory syndrome-related coronavirus / classification
-
Severe acute respiratory syndrome-related coronavirus / genetics*
-
Severe acute respiratory syndrome-related coronavirus / isolation & purification
-
Spike Glycoprotein, Coronavirus
-
Viral Envelope Proteins / genetics
Substances
-
Membrane Glycoproteins
-
RNA, Viral
-
Spike Glycoprotein, Coronavirus
-
Viral Envelope Proteins
-
spike glycoprotein, SARS-CoV